Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rat lens aldose reductase (RLAR) is an enzyme that catalyzes the reduction of glucose to sorbitol, a key step in the polyol pathway. It is implicated in the development of diabetic complications, particularly cataracts, due to the accumulation of sorbitol in the lens. RLAR also participates in detoxification of aldehydes and antioxidant defense. It is a target for aldose reductase inhibitors, which aim to prevent or delay these complications.
Inhibition of aldose reductase, preventing the conversion of glucose to sorbitol
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rat Lens Aldose Reductase (RLAR).